Stock & Company Details
Immunome Inc $IMNM
Price:
N/A
N/A
114M
$2.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.17
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IMNM technical indicators
Latest Immunome Inc (IMNM) indicator readings as of 2026-10-09.
IMNM's 14-day RSI is 30.2, in neutral territory. At $19.55 it is trading 13.9% below its 200-day moving average of $22.72, and below its 50-day average of $24.94. Price sits near the lower Bollinger Band ($18.18 to $26.21). ADX reads 32.3, indicating a trending market.
Overview
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. It primarily operates in the U.S. Its current programs comprise Oncology (IMM-ONC-01), SARS-CoV-2 (IMM-BCP-01), and IMM20059 Anti-EPN1.
Finance Bot
Ask your questions
Start by typing a question below.
